Delorean Lands $5.76M Government Cash Refund With Another Due in FY2027
Delorean secures $5.76 million R&D tax cash refund for FY2025
Delorean Corporation (ASX: DEL) has received a $5.76 million R&D tax cash refund relating to eligible research and development expenditure incurred during FY2025. A further cash refund is also expected in FY2027, connected to eligible R&D expenditure being incurred in the current financial year (FY2026).
Delorean is a leading Australian bioenergy company specialising in the design, build, ownership, and management of bioenergy infrastructure, operating across the renewable energy and waste management sectors.
When big ASX news breaks, our subscribers know first
What is the Australian R&D Tax Incentive — and why does it matter for DEL investors?
The Australian Federal Government’s R&D Tax Incentive is a government program that provides cash refunds to eligible Australian companies for qualifying research and development activities. Unlike a standard tax deduction, which simply reduces the amount of income that is taxed, this program delivers an actual cash payment back to the company. That distinction matters for investors: the refund directly strengthens a company’s cash position rather than providing a deferred or notional benefit.
Key facts about the R&D Tax Incentive program:
- What it is: A Federal Government program that refunds a portion of eligible R&D expenditure to qualifying Australian companies
- Who is eligible: Companies incorporated in Australia that conduct genuine, eligible R&D activities
- What “cash refund” means: A direct cash payment returned to the company, not a future tax credit or deduction against future income
- Typical refund rates: Eligible companies with an aggregated annual turnover of less than $20 million can generally access a refundable tax offset of 43.5% on eligible R&D expenditure under the program’s standard parameters
For Delorean, the nature of its business positions it squarely within this framework. Designing, building, and operating bioenergy infrastructure involves genuine experimental and developmental activity, making its R&D expenditure a natural fit for program eligibility.
How Delorean’s three divisions drive R&D activity
Delorean operates across three divisions that together cover the full bioenergy project lifecycle, from initial engineering through to energy monetisation. This integrated structure means R&D activity occurs at multiple points in the company’s operations, underpinning its eligibility for the program on an ongoing basis.
| Division | Key Function | R&D Relevance |
|---|---|---|
| Engineering Division | Design and development of bioenergy infrastructure | Technical innovation in system design and project conception |
| Infrastructure Division | Build, ownership, and management of bioenergy assets | Development and testing of organic waste processing infrastructure |
| Energy Retail Division | Monetisation of green electricity, heat, and gas | Development of energy commercialisation models and revenue stream optimisation |
The next major ASX story will hit our subscribers first
Cash in hand — what the refund signals for Delorean’s investment case
The $5.76 million refund represents a non-dilutive cash injection, meaning the company receives a meaningful balance sheet boost without issuing new equity or taking on debt. For a small-cap company actively investing in infrastructure development, this kind of funding mechanism preserves shareholder value while supporting continued operations.
The forward-looking element of the announcement adds further context. A second refund is anticipated for FY2026 expenditure, suggesting the R&D program is a recurring feature of Delorean’s financial profile rather than an isolated event. This reflects an ongoing commitment to R&D investment across a company operating in two high-growth sectors: renewable energy and waste management.
Key investor takeaways from this announcement:
- Cash received and in hand: The $5.76 million refund has been received, representing an immediate addition to Delorean’s cash position
- Second refund on the horizon: A further refund is anticipated in FY2027 for eligible expenditure incurred during FY2026, indicating program participation is ongoing
- Non-dilutive funding: The refund supports continued R&D and infrastructure build-out without requiring equity issuance, protecting existing shareholders from dilution
Don’t Miss the Next Renewable Energy Winner
Big News Blast delivers FREE breaking ASX news straight to your inbox within minutes of release, complete with in-depth analysis already done for you. Join 20,000+ investors who never miss a market-moving announcement. Click the “Free Alerts” button at Big News Blast to start receiving alerts the moment news breaks.